INDOUS

Indo US Bio-Tech Ltd.

NSE: INDOUS

BSE: 541304

Sector: Fast Moving Consumer Goods

Industry Group: Agricultural Food & other Products

Industry: Other Agricultural Products

74.15-2.6 (-3.39%)

5 Oct, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

30.3 / 100

Value Score

88.3 / 100

Price Momentum Score

4.6 / 100

QVM Score

28.2 / 100

Key Metrics

Market Cap

155.36

P/E (TTM)

13.56

P/B

1.68

P/S (TTM)

1.38

EV/EBITDA

11.24

CAPE (5Y)

14.53

ROE (TTM)

15.34

ROCE (TTM)

14.45

ROA (TTM)

11.36

Avg 3Y ROE

17.48

Earnings 3Y CAGR

20.33

Sales 3Y CAGR

21.39

Sales 5Y CAGR

22.47

Debt/Equity

0.40

Consensus TP

Strong Buy %

Promoter Holding

68.29

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Indo US Bio-Tech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and reasonably valued with respect to the industry

PE TTM of 13.56 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is modest at -8.93%

What is P/E Ratio?

Median: 14.89

Value 13.56

1.16439.38

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.4 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.21 in the last 1 year

What is Debt to Equity?

Negative

Weak price momentum

Price Momentum score of 4.6 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

4.6 / 100

Moderate operating margin but declining trend

The company reported moderate operating margin of 14.59% for 12-month ended 30 Jun 2026 but operating margin declined by -325 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 2.52% for 12-month ended 30 Jun 2026 and the growth was 4.28 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 6.8

Value 2.52

-91.765336.1

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -35.87% for 12-month ended 30 Jun 2026 and the growth was 39.06 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Company's earnings are of low quality

Earnings quality score of 20.5 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

20.5 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

High ROE but declining trend

The company reported strong ROE of 15.34% for 12-month ended 30 Jun 2026 but ROE declined by -769 bps from 1 year ago

What is ROE (FY)?

Financial Snapshot

See detailed analysis

Multi-year trends for Indo US Bio-Tech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Indo US Bio-Tech Ltd. Shareholding Pattern

Quarterly breakdown of Indo US Bio-Tech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	70.54	70.54	72.19	73.01	73.01	73.01	73.01	73.01	73.01	73.01	74.02	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	68.29	68.29
Indian Promoter	70.54	70.54	72.19	73.01	73.01	73.01	73.01	73.01	73.01	73.01	74.02	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	70.17	68.29	68.29
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.18	0.01
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.18	0.01
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	29.46	29.46	27.81	26.99	26.99	26.99	26.99	26.99	26.99	26.99	25.98	29.83	29.83	29.83	29.83	29.83	29.83	29.83	29.83	29.82	29.83	29.83	29.83	29.83	31.53	31.70
Bodies Corporate	0.80	0.78	1.26	1.90	2.37	2.33	1.98	1.81	1.77	1.75	1.67	3.54	3.63	3.68	3.67	3.52	3.48	3.51	3.76	3.78	3.62	3.60	3.79	4.22	5.03	5.19
Others (incl. Retail) No. of shareholders	28.66 182	28.68 180	26.55 167	25.09 165	24.62 177	24.66 190	25.01 206	25.18 254	25.22 246	25.24 247	24.31 224	26.29 248	26.20 224	26.15 240	26.16 306	26.31 1,209	26.35 1,149	26.32 1,116	26.07 949	26.04 2,798	26.21 2,752	26.23 3,084	26.04 4,099	25.61 4,702	26.50 4,497	26.51 4,662

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Indo US Bio-Tech Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
INDO US AGRISEEDS LIMITED Promoter Group	March-2026	Market Sale (Disposal) 5th Mar 2026	9.07 %	₹ 141.00	50.00 k	₹ 70.50 lac
INDO US AGRISEEDS LIMITED Promoter Group	February-2026	Market Sale (Disposal) 18th Feb 2026	9.32 %	₹ 140.00	50.00 k	₹ 70.00 lac
INDO US AGRISEEDS LIMITED Promoter Group	February-2026	Market Sale (Disposal) 12th Feb 2026	9.70 %	₹ 130.00	75.00 k	₹ 97.50 lac
INDO US AGRISEEDS LIMITED Promoter Group	February-2026	Market Sale (Disposal) 11th Feb 2026	10.20 %	₹ 130.00	1.00 lac	₹ 1.30 cr
INDO US AGRISEEDS LIMITED Promoter Group	February-2026	Market Sale (Disposal) 10th Feb 2026	10.21 %	₹ 126.00	2.25 k	₹ 2.84 lac
INDO US AGRISEEDS LIMITED Promoter Group	February-2026	Market Sale (Disposal) 9th Feb 2026	10.71 %	₹ 126.00	1.00 lac	₹ 1.26 cr

Corporate Actions

History of Indo US Bio-Tech Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.25/share
Record date: 3rd Dec 2024Ex-date: 3rd Dec 2024
Announced on: 13th Nov 2024
Bonus1 new shares for 1 existing shares
Ex-date: 29th Aug 2023Announced on: 7th Jul 2023
Bonus1 new shares for 5 existing shares
Ex-date: 29th Nov 2021Announced on: 10th Oct 2021
Dividend₹ 0.25/share
Record date: 29th Oct 2021Ex-date: 28th Oct 2021
Announced on: 10th Oct 2021
Bonus1 new shares for 4 existing shares
Ex-date: 23rd Apr 2019Announced on: 7th Mar 2019

Company Profile

Overview of Indo US Bio-Tech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Indo US Bio-Tech Limited is a specialized agriculture seed company with its own research station, marketing network and seed production bases. The Company operates through the Seed Cultivation, processing and trading segment. It is involved in crop research and development through breeding, producti...

Key personnel

Ms. Rinku Dipenbhai Jethva

Chief Financial Officer

Ms. Dimpy Joshi

Compliance Officer, Company Secretary

Mr. Jagdish Devjibhai AjudiaD

Managing Director, Executive Director

Mrs. Maltiben Jagdishbhai AjudiaD

Wholetime Director

Ms. Priyanka Jagdishbhai AjudiaD

Executive Director

Mrs. Shilpa Chetanbhai ThumarD

Additional Independent Director

Mrs. Ritaben Nileshbhai KikaniD

Non-Executive Independent Director

Mrs. Hemanshi Darsh SoniD

Additional Non-Executive Independent Director

Incorporated on

04 Feb 2004

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

11 May 2018

Free Float

49,15,100

Address

Frequently Asked Questions

What is the current share price of Indo US Bio-Tech Ltd.?

The current share price of Indo US Bio-Tech Ltd. is ₹ 74.15 as of 5 Oct 2026.

What is the market capitalisation of Indo US Bio-Tech Ltd.?

The market capitalisation of Indo US Bio-Tech Ltd. stands at ₹ 155.36 Cr.

What is the PE ratio of Indo US Bio-Tech Ltd.?

The Price-to-Earnings (PE) ratio of Indo US Bio-Tech Ltd. is 13.56 as of the latest trailing twelve months data.

What is the ROE and ROCE of Indo US Bio-Tech Ltd.?

Indo US Bio-Tech Ltd. has a Return on Equity (ROE) of 15.34% and a Return on Capital Employed (ROCE) of 14.45% as per the latest financial reports.

What is the 52-week high and low of Indo US Bio-Tech Ltd.?

The 52-week high of Indo US Bio-Tech Ltd. is - and the 52-week low is -.

What is the dividend yield of Indo US Bio-Tech Ltd.?

The dividend yield of Indo US Bio-Tech Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Indo US Bio-Tech Ltd.?

Foreign Institutional Investors (FII) hold 0.01%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 26.51% of Indo US Bio-Tech Ltd. shares.

What sector does Indo US Bio-Tech Ltd. belong to?

Indo US Bio-Tech Ltd. operates in the Fast Moving Consumer Goods sector.

What is the beta of Indo US Bio-Tech Ltd.?

The beta of Indo US Bio-Tech Ltd. is 1.06, indicating its price volatility relative to the broader market. Over the past 1 year, Indo US Bio-Tech Ltd. has delivered an absolute return of -43.65%.

What is the RSI of Indo US Bio-Tech Ltd.?

The 14-day Relative Strength Index (RSI) of Indo US Bio-Tech Ltd. is 43.99, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Indo US Bio-Tech Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Indo US Bio-Tech Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile